Matinas BioPharma Holdings Inc (MTNB)
0.1749
-0.01
(-4.58%)
USD |
NYAM |
May 03, 16:00
0.1749
0.00 (0.00%)
After-Hours: 20:00
Matinas BioPharma Holdings Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.0019 |
| Date | Value |
|---|---|
| December 31, 2018 | 0.0124 |
| September 30, 2018 | 0.031 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.005 |
| December 31, 2017 | 0.0159 |
| September 30, 2017 | 0.0233 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.0025 |
| December 31, 2016 | 0.0165 |
| September 30, 2016 | 0.0217 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.0014 |
| June 30, 2015 | 0.0012 |
| March 31, 2015 | 0.0016 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
--
Maximum
Jun 2019
--
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 25.10M |
| Total Liabilities (Quarterly) | 5.858M |
| Shareholders Equity (Quarterly) | 19.25M |